Many patients value conversations with their rheumatologists and oncologists more than just reading information from a website.

Lupin partners with Zentiva Group for global commercialisation of Certolizumab Pegol biosimilar, sharing profits and investments.

When psoriatic arthritis symptoms are under control, you may be tempted to stop taking medication. Here’s why that’s a bad idea.

As Southern Utah students get ready for another year of learning, Paradise Canyon Eye Care wants parents to remember one of ...

Rheumatoid arthritis and spondyloarthritis are long-lasting inflammatory diseases that gradually wear down joints. While ...

Claire King has played Kim Tate on and off in Emmerdale for more than 30 years - and she told how she drew on her own heartache for some of the character's most emotional scenes ...

Lymphatic drainage is said to help with everything from energy and immunity to cellulite and water retention. But does it ...

Articularis Rheumatology Specialists (ARS), a division of Articularis Healthcare Group (AHG), is pleased to announce the ...

Upadacitinib demonstrated greater clinical efficacy and a comparable safety profile to adalimumab for treating RA, regardless of patients’ baseline CV risks.

A new clinical test may be able to predict which biologic may be the most effective for each individual with rheumatoid ...

Lupin & Zentiva ink licensing and supply agreement for commercializing biosimilar Certolizumab Pegol: Our Bureau, Mumbai Wednesday, July 9, 2025, 16:20 Hrs [IST] Global Pharma maj ...

The hot flashes and night sweats that plague breast cancer survivors during years-long hormone-suppressing therapy are eased ...